vitiligo

Vine jungle rainforest
Biotech

Vyne's BET inhibitor fails phase 2 vitiligo trial, sinking stock

The bad news keeps on coming for Vyne Therapeutics’ BET inhibitor platform.
James Waldron Jul 30, 2025 9:35am
Two hands with vitiligo holding each other

Sugar from soil bacteria restores pigment in mice with vitiligo

Jan 31, 2025 1:32pm
Pac man eat MA deal buy sell merger

'Expect us to act' on M&A, AbbVie CEO says

Feb 9, 2023 2:29pm
photo of a pair of hands that show the skin condition vitiligo

Incyte scoops up preclinical biotech to widen vitiligo footprint

Oct 3, 2022 11:20am